The 23 linked references in paper O Vasil'eva S., L. Kuz'mina P., N. Kravchenko Yu., О. Васильева С., Л. Кузьмина П., Н. Кравченко Ю. (2017) “Роль молекулярно-генетических исследований в диагностике и профилактике развития профессиональных заболеваний органов дыхания // A role of molecular analysis for diagnosis and prevention of occupational lung diseases” / spz:neicon:pulmonology:y:2017:i:2:p:198-205

  1. Bang K.M. Chronic obstructive pulmonary diseases in nonsmokers by occupation and exposure: a brief review. Curr. Opin. Pulm. Med. 2015, 21 (2): 149–154. DOI: 10.1097/ MCP.0000000000000135.
  2. 3): 529–545. DOI: 10.1183/09031936.00096111. 3. Nicholson P.J., Cullinan P., Burge P.S., Boyle C. Occupational asthma: Prevention, identification and management: Systematic review and recommendations. London: British Occupational Health Research Foundation; 2010. Available at: EvidenceReview-Mar2010.pdf
  3. Henneberger P.K., Redlich C.A., Callahan D.B. et al. An official American Thoracic Society statement: work-exacerbated asthma.Am. J. Respir. Crit. Care Med.2011; 184 (3): 368–378. DOI: 10.1164/rccm.812011ST.
  4. Lopez A.D., Shibuya K., Rao C. et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 2006; 27 (2): 397–412. DOI: 10.1183/ 09031936.06.00025805.
  5. Salvi S. Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease. Clin. Chest Med. 2014; 35 (1): 17–27. DOI: 10.1016/j.ccm.2013.09.011.
  6. Fishwick D., Sen D., Barber C. et al. Occupational chronic obstructive pulmonary disease: a standard of care.Occup. Med.(Lond.). 2015; 65 (4): 270–282. DOI: 10.1093/occmed/ kqv019.
  7. Bang K.M., Syamlal G., Mazurek J.M., Wassell J.T. Chronic obstructive pulmonary disease prevalence among nonsmokers by occupation in the United States.J. Occup. Environ. Med. 2013; 55 (9): 1021–1026. DOI: 10.1097/ JOM.0b013e31829baa97.
  8. Lamprecht B., McBurnie M.A., Vollmer W.M. et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011; 139 (4): 752– 763. DOI: 10.1378/chest.10-1253.
  9. Christiani D.S., Mehta A.J., Yu C.L. Genetic susceptibility to occupational exposures. Occup. Environ. Med.2008; 65 (6): 430–436. DOI: 10.1136/oem.2007.033977.
  10. Shulte P.A., Whittaker C., Curran C.P. Consideration for Using Genetics and Epigenetic Information in Occupational Health Risk Assessment and Standard Settings. J. Occup. Inviron. Hyg. 2015; 12 (Suppl. 1): S69–S68. DOI: 10.1080/15459624.2015.1060323.
  11. Brandt-Rauf P.W., Brandt-Rauf S.I. Genetic testing in the workplace: ethical, legal, and social implications. Ann. Rev. Public Health. 2004; 25: 139–153. DOI: 10.1146/annurev. publhealth.25.101802.123012.
  12. Chiu W.A., Euling S.Y., Scott C.S., Subramaniam R.P. Approaches to advancing quantitative human health risk assessment of environmental chemicals in the post-genomic era. Toxicol. Appl. Pharmacol. 2013; 271 (3): 309–323. DOI: 10.1016/j.taap.2010.03.019.
  13. Mapp C.E., Boscetto P., Maestrell P., Fabri G.M. Occupational asthma. Am. J. Respir. Crit. Care Med. 2005; 172 (3): 280–305. DOI: 10.1164/rccm.200311-1575SO.
  14. Chung C.C., Magalhaes W.C.S., Gonzalez-Bosquet J., Chanock S.J. Genome-wide association studies in cancer–current and future directions. Carcinogenesis. 2010; 31 (1): 111–120. DOI: 10.1093/carcin/bgp273.
  15. Cullen A.C., Corrales M.A., Kramer C.B., Faustman E.M. The application of genetic information for regulatory standard setting under the clean air act: a decision-analytic approach. Risk. Anal. 2008; 28 (4): 877–890. DOI: 10.1111/ j.1539-6924.2008.01084.x. (the paper at Socionet)
  16. Dolinoy D.C., Weidman J.R., Jirtle R.L. Epigenetic gene regulation: Linking early development to adult disease. Reproduct. Toxicol.2007; 23: 297–298. DOI: 10.1016/ j.reprotox.2006.08.012.
  17. Grodsky J.A. Genetics and environmental law: redefining public health. Calif. Law Rev. 2005; 92 (1): 171–270. DOI: 10.15779/Z38QQ74.
  18. Murcray C.E., Lewinger J.P., Gauderman W.J. Gene-environment interaction in genome-wide association studies. Am. J. Epidemiol.2009; 169 (2): 219–226. DOI: 10.1093/ aje/kwn353.
  19. Faisal M., Chellurl P.E., Singaraju S. et al. Environmental and occupational respiratory diseases. Spirometric abnormalities in nonsmoking bus drivers of hyderabad. World Allergy Org. J. 2013; 6 (Suppl. 1): P61. DOI: 10.1186/19394551-6-S1-P61.
  20. Васильева О.С., Кулемина Е.А. Бронхиальная астма, вызванная ингаляцией токсико-аллергенных аэрозолей поливинилхлорида. Пульмонология. 2012; (1): 112–116.
  21. Васильева О.С., Кузьмина Л.П., Кулемина Е.А., Коляскина М.М. Клинические и молекулярно-генетические аспекты формирования профессиональной астмы. Пульмонология. 2012; (3): 39–45.
  22. Buist A.S., McBumie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007; 370 (9589): 741–750. DOI: 10.1016/S0140-6736(07)61377-4.
  23. Eisner M.D., Blanc P.D., Omachi T.A. et al. Socioeconomic status, race and COPD health outcomes. J. Epidemiol. Community Health.2011; 65 (1): 26–34. DOI: 10.1136/jech.2009.089722.